Substance Use Disorders in Pregnancy

Size: px
Start display at page:

Download "Substance Use Disorders in Pregnancy"

Transcription

1 + Substance Use Disorders in Pregnancy Laura Lander, MSW, LICSW, Assistant Professor Emily Chilko, MSW, LICSW, Clinical Therapist Department of Behavioral Medicine and Psychiatry, WVU NASW Conference May 2018

2 + Overview of Today s Topics Brief Review of Emergence of Opioid Epidemic Brief Review of Diagnostic Criteria for SUDs Prevalence of Substance Use and SUDs During Pregnancy Impact of Substance Use on Developing Fetus Clinical Presentation of Pregnant Patients Unique Strengths of Pregnant Patients Unique Concerns in Treating Pregnant Patients A Review of Effective Treatment Models Stigma

3 + From Illness to Epidemic Substance Use Disorders in Today s Appalachia

4 + Overdose Deaths in 1999

5 + Overdose Deaths in 2014

6 + Central Appalachia in 1999

7 + Central Appalachia in 2014

8 + What Changed? Known Changes Radical shift in prescribing practices of Opioid pain pills Subsequent increased drug availability Pain as the 5 th vital sign Theorized Changes Increased Poverty and Despair resulting from increasing economic disparity between America s socioeconomic classes Increased incidences of Chronic Pain and Economic Decline in Post-Industrialized Regions of the U.S. Death of Community - decreasing attachment to religious and civic institutions Poverty of Spirit - resulting from unprecedented pressures of globalization Criminalization of Illness through changes in sentencing law and policy resulting in increased incarceration rates Healthcare as a Business offering access to quality prevention and treatment only for individuals who can afford to pay

9 + Understanding Diagnostic Criteria Knowing What SUD Is and Is Not

10 + What is Substance Use Disorder? Impaired Control 1. Using more or for longer than intended 2. Difficulty stopping 3. Significant time spent 4. Intense cravings Social Impairment 5. Continued use despite problems with role responsibilities 6. Strained relationships 7. Giving up previous sources of joy Risky Use 8. Using in ways that are dangerous 9. Continued use despite physical or mental problems Pharmacological Indicators 10. Tolerance 11. Withdrawal

11 + What do you notice is NOT included in the criteria?

12 + What is Substance Use Disorder? SUD Criteria does NOT include Type of Substance Used Quantity of Substance Used Frequency of Substance Used Whether Substance is legal/illegal These are still essential questions to ask, but are not necessarily indicative of a SUD diagnosis. Addiction is not what s in your blood stream, it s more about how well or poorly you re functioning in your life as a result of what s in your blood stream.

13 + Substance Use Disorders + Pregnancy How Significant is This Problem?

14 + Prevalence of the Problem NSDUH 2013 illicit drug use Pregnant women age % Pregnant women age % Pregnant women % Rates of heroin use increased 31% from Stitely, samples or chord blood taken for drugs or alcohol (19.2%) Over 1 million babies are born every year to mothers who abuse substances Over 4,000 in WV Treatment improves birth outcomes!

15 + Tobacco Use During Pregnancy WV Behavioral Health Epidemiological Profile, 2013 On Average, 30% of women who smoked 3 months before pregnancy quit before the last 3 months of pregnancy

16 + Tobacco Use During Pregnancy WV Behavioral Health Epidemiological Profile, 2013

17 + Risks of Tobacco Use in Pregnancy SIDS Prematurity Asthma Low birth weight Still birth ( greater risk, greater the heavier the use)

18 + Alcohol Use During Pregnancy WV Behavioral Health Epidemiological Profile, 2013 Nationally, in % of pregnant women reported current use of alcohol and 2.3% reported binge drinking (NSDUH, 2013) First trimester 19% Second trimester - %5 Third trimester - 4.4% In WV in 2010, 3.7% of women reported drinking alcohol the last three months of pregnancy. Pregnant women aged 35 and over had the highest percentage of drinking alcohol the last 3 months of pregnancy in West Virginia. In 2010, women with the lowest and highest income (< $10,000 and > $50,000) reported the highest use of alcohol in the last three months of pregnancy (PRAMS).

19 + Risks of Alcohol Use in Pregnancy Fetal Alcohol Syndrome 2-5% of live births in US Short stature Abnormal facial features Neurodevelopmental disability Cognitive impairment

20 + Cannabis Use During Pregnancy Most commonly abused drug among pregnant women 11.63% of pregnant women report cannabis use in the last year of pregnancy 7.47% age report use in the last month 2.12% age (Brown, 2017) Some doctors even support the use of cannabis in pregnancy to control symptoms of morning sickness In WV, there is a common perception that marijuana is not harmful or addictive.

21 + Risks of Cannabis Use in Pregnancy Low birth weight Still births 2.3x greater risk Smaller head circumference Poor cognitive functioning Hyperactivity Attentional issues

22 + Opioid Use During Pregnancy In a CDC study, 39% of women on Medicaid were prescribed opioids during their pregnancy , 28% or women with private insurance.

23 + Risks of Opioid Use in Pregnancy Preeclampsia Low birth weight Placental insufficiency and abruption Premature rupture of the membranes Preterm labor Neonatal Abstinence Syndrome Maternal infection associated with IV use (Hep C, HIV, Endocarditis)

24 + Neonatal Abstinence Syndrome Postnatal Withdrawal Syndrome 5-fold U.S. increase from CDC study of 28 states, , showed overall increase of ~300%, from 1.5 to 6.0/1,000 hospital births* in 2013, WV had 33.4 cases/1,000 hospital births = highest rate est. 80% of hospital costs for NAS covered by WV Medicaid *CDC. Incidence of Neonatal Abstinence Syndrome-28 States, MMWR August 12,2016; 65(31);

25 + Neonatal Abstinence Syndrome Symptoms of NAS Irritability excessive crying, difficult to console Feeding problems Sleep problems Excessive sucking Diarrhea Vomiting Exaggerated startle response Seizures (infrequent) Unknown long term impact

26 + Risks of Stimulant Use During Pregnancy Cocaine and Other Stimulants 25% increase chance of preterm labor Placental abruption Small head circumference Low birth weight Withdrawal when born Learning difficulties, cognitive deficits

27 + Risks of Benzodiazepine Use in Pregnancy Withdrawal, seizures for mother Cleft palate (small increased risk), data controversial Unknown long term effects

28 + Issues Unique to Pregnant Patients a Review of Strengths and Challenges Painting by Annie Preece; person in recovery

29 + Trends Among Pregnant SUD Patients Pregnant Patients Are often are highly motivated to change Can be less ambivalent about getting clean Tend to be younger Have a shorter progression of disease Can be emotionally labile Can be overwhelmed Often have family support Are hopeful about the future Have high level of willingness

30 + Treatment of SUDs in Pregnancy Access to treatment can be limited Coordination with Obstetrical Care is essential Participation in SUD treatment increases OBGYN care adherence Increased stigma vs. non-pregnant peers Treatment in all pregnancy treatment groups can reduce stigma and shame and increase social supports

31 + Unique Treatment Concerns Higher rates of domestic violence High levels of shame and guilt Fear of CPS intervention Women with addiction often do not have regular menses so may not realize they are pregnant right away Childcare issues Transportation issues Employment issues/financial limitations At risk for medial complications Need for discussions about contraceptive care post-delivery

32 + Post-Delivery Challenges Increased risk of relapse Increased risk of dropping out of treatment Post-partum depression Post-partum anxiety Negative family interactions Guilt and Shame

33 + Summary of Risks to Neonates Risks when Maternal SUDs are Untreated Obstetric/Pediatric complications Miscarriage Preeclampsia Preterm birth Operative deliveries Low birth weight Birth defects NICU admissions Sudden infant death syndrome Behavioral complications Poor infant self-regulation Insecure attachment developmental delays ADHD Anxiety disorders Conduct disorders It is very difficult to tease out effects of intrauterine drug exposure and environmental exposure post delivery.

34 + Maternal Effects on Disease Susceptibility

35 + Breastfeeding

36 + Breastfeeding WHO encourages breastfeeding for mothers including those receiving medication-assisted treatment as long as the mother is not using other substances. Research has shown breastfeeding improves outcomes for neonates. Skin-to-skin Bonding Protective benefits of breast milk The amount of MAT medication the babies get is minimal. Buprenorphine needs to be absorbed sublingually to get greatest benefit, when passed through the digestive system it is destroyed.

37 + Benefits of Breastfeeding For baby Reduced: allergies, asthma, obesity, celiac disease, SIDS, IBS, Childhood leukemia, ear infections Enhanced: mother/baby bonding, emotional security, increased IQ, financial security for family For mother Reduced: breast cancer, ovarian cancer, osteoporosis, diabetes, less work time missed, clean up Enhanced: sleep, financial savings, mothering skills and confidence

38 + Treatment Best Practices Comprehensive Opioid Addiction Treatment

39 + Treatment Options During Pregnancy Inpatient Detoxification Residential Treatment Programs Outpatient Therapy Outpatient Medication-Assisted Treatment (MAT) For Opioid Use Disorders Methadone Suboxone (Buprenorphine/Naloxone) Subutex (Buprenorphine)

40 + Medication-Assisted Treatment Methadone

41 + Medication-Assisted Treatment Buprenorphine (Subutex)

42 + Medication-Assisted Treatment Buprenorphine+Naloxone (Suboxone) Available in Tablets and Films

43 + Medication-Assisted Treatment

44 + Why put a pregnant patient on medication that may result in withdrawal for the baby?

45 + Risks and Benefits of MAT Benefits Prevents withdrawal Reduces cravings Blocks euphoric effects Enhances treatment retention Reduces relapse Reduces fetal exposure to illicit drugs Stabilized intrauterine environment Enhances involvement in prenatal care Reduced Costs Risks Risk of Neonatal abstinence syndrome Pain management issues Risk of abuse/diversion Familial conflict

46 + Detoxification alone does not work. Relapse rate is 90+%.

47 + Comprehensive Opioid Addiction Treatment The WV model Beginner 1-90 days abstinent Weekly group therapy Signed meeting lists Monthly individual therapy Intermediate days abstinent Bi-weekly group therapy Written report/no signatures required Monthly individual therapy Advanced >365 days Monthly group Mandatory meetings no longer required Monthly individual therapy no longer required

48 + Treatment Components In a beginner group Weekly medication management group with psychiatrist Weekly group therapy Random urine drug screens, can be observed Monthly individual therapy Participation in community based recovery meetings four times per week Work with a sponsor, recovery coach Open communication between our team and patient s OB Random pill counts Additional items at the team s discretion Requirements are less intensive as patients advance in program tiers.

49 + Therapeutic Considerations Establishing a trusting relationship and building rapport Psychoeducation about addiction Disease model, neurobiology of addiction Relapse prevention Stages of change, skills acquisition Managing Feelings Coping strategies Interpersonal relationships Impact on family Establishing social supports Self-help

50 + Compassion + Consequences Use a compassionate approach Addiction is a disease of the brain Link between trauma + SUDs Guilt and shame as relapse triggers Compassion is effective! (Especially when combined with clear expectations and consequences.) Hold patients accountable for their actions Every action will have a consequence. Expectations are clear and communicated at intake.

51 + The Value of Treatment Every dollar invested in addiction treatment programs yields a return of between $4 and $7 in reduced drugrelated crime, criminal justice costs, and theft. When savings related to healthcare are included, total savings can exceed costs by a ratio of 12 to 1. Drugabuse.gov

52 + Childhood Trauma + Addiction What We Learned from the ACEs Study

53 + The ACEs Study

54 + The ACEs Study

55 + What is the greatest barrier to treatment for pregnant women?

56 + STIGMA

57 + Video

58 + What is Stigma An attitude, behavior or condition that is socially discrediting Major influences regarding stigma are beliefs about cause and controllability Language and terminology strongly influence stigma Research shows that Addiction is the most stigmatized condition world wide (Room, 2005) Even among health care providers More stigmatized than other mental health conditions

59 + What factors influence stigma Cause Controllability Stigma It s not their fault. You don t choose to have a SUD They can t just stop. Quitting requires help. Decreases It is their fault. Their choices caused their addiction. They really can help it. They could stop if they really wanted to. Increases

60 + Beliefs about Causality Moral Model It s a lifestyle choice They choose to drink and use drugs Self-destructive, immoral, irresponsible, frustrating, revolting, lying, thieving, cheating, criminal, willful misanthropes Disease Model People have a disease Stress-induced defect in the midbrain s ability to properly perceive pleasure Craving is true suffering Bad People Sick People

61 + Drinking vs. Drunkenness Alcohol consumption begins to rise after the revolutionary war (1783), and surged in the 1830s Excessive Drinking initially considered a moral depravity The term alcoholism was introduced in 1849 by Swedish physician Magnus Huss, in the US the terms most common to describe alcoholism were dipsomania and inebriety. The term alcoholic began to be used by professionals in the early 1900s The term addiction began to be used in the professional literature in the mid 1890s

62 Dis-ease..Drunkenness resembles certain hereditary, family and contagious diseases.. Nearly all diseases have their predisposing causes including intemperate use of distilled spirits 1784 Dr. Benjamin Rush Father of American psychiatry

63 + Temperance Movement Temperance movement - moderation Fueled by public drunkenness Goal was moderation drinking Early efforts were to encourage whiskey drinkers to drink beer instead, but it did not work Temperance movement - abstinence Religiosity, Alcohol framed as evil Only solution is to abstain Let the drunkards die off The Stigma of Alcohol Use Disorders is born

64 + History of Self-Help Washingtonians First widely available mutual aid society Tried to reduce stigma Mid 1800s fraternal temperance societies and reform clubs 1935 Alcoholics Anonymous Narcotics Anonymous

65 + The rise of drug addiction Incidence of opioid use disorders rose in the early 1900s and Medication-assisted treatment was available The Harrison Act of 1914 Criminalized drug use and addiction Criminalized the treatment of SUDs by physicians over 25,000 physicians indicted for treating individuals with SUDs Morphine maintenance clinics shut down Further Stigmatization of Substance Use Disorders

66 + 20 th Century th Amendment (National Prohibition) Repealed with the 21 st amendment in 1933 The Harrison Act and policies of Bureau of Narcotics pushed people with SUDs underground 1951 Boggs Act increased sentences for drug violations and mandatory minimum sentences 1956 Narcotic Control Act sentences for dug offences could include life sentenced or the death penalty Widely held belief that alcoholism and drug addiction were moral failings

67 + History of the Disease Model of Substance Use Disorders Early 1800 s awareness of alcoholism effecting liver, stomach, blood and nerves and delirium tremens as well as psychosis 1946 EM Jellinek progressive disease 1954 WHO recognizes Alcoholism as Disease 1956 AMA recognize Alcoholism as Disease 1960 Jellineck s Disease Concept of Alcoholism 1960 s Minnesota Model 28 day treatment

68 + Recent History political influence (anonymous people) 1960s and 70s 13 laws were passed to promote and develop a public health response to addiction and alcoholism, ground swell of community support and members of the recovery community testifying in the senate

69 + Criminalization of Substance Use Disorders Early 1970 s - Nixon Undercut this momentum drugs are public enemy #1 Penalties against the possession of a drug should not be more damaging to an individual than the use of the drug itself Jimmy Carter s - Reagan War on Drugs Return to criminalization of SUDs Crack epidemic From 1985 to today 80%+ of individuals who are incarcerated are there for nonviolent drug related crimes

70 +.Enter neuroscience and the understanding of the brain

71 + Nora Volkow on the science of addiction The Disease Model

72 + Science

73 + Impact of Stigma People fail to access or engage in treatment because of fear of what people might think; they don t want to be an addict Medical profession often fails to treat patients appropriately, like not using FDA-approved medications Mental health programs may exclude SUD patients Funding for SUD treatment is insufficient to meet the demand SUD patients are frequently sent to prison rather than treatment programs People in recovery are always under suspicion If patients have a criminal history because of their drug use, then this causes future stigma in terms of employment, housing & educational loans SOURCE: Dr. Richard Juman, The Deadly Stigma of Addiction, 12/05/12

74 + Why Reducing Stigma Matters World wide alcohol kills 3.3 million people a year, 350,000 die due to illicit drugs (WHO, 2015) 23 million people in the US have a substance use disorder Economic cost attributable to substance use disorders as a result of lost productivity, health care costs and criminal justice - $600 billion Despite 14,000 treatment facilities, 100,000 recovery support chapters meeting weekly in the US, only 10% of people receive help Main barrier to seeking and receiving help is stigma

75 + Reducing Stigma Stigma occurs at many levels Public Private Personal Stigma becomes a barrier to acknowledging the problem and accessing help and remaining in treatment Stigma about SUDs reinforces the misperceptions about cause and controllability

76 + Recommended Language Use person-first language & medically accurate terms

77 + The Role of Social Workers Social Workers can influence stigma With patients by Helping to reduce guilt and shame Offering moral support Respecting confidentiality Adopting a non-judgmental stance Treating the pregnant patient like any other patient with a chronic illness By advocating for patients who voice discrimination Other ways?

78 + The of Social Workers Social Workers can influence stigma With co-workers by Educating colleagues about SUDs being a brain disease Sharing stories of success Within ourselves by Being aware of your own biases Changing our language Finding support for transference issues we face Other ways?

79 + Instill Hope

80 + References Helmbrecht GD, Thiagarajah S. Management of addiction disorders in pregnancy. Journal of Addiction Medicine. 2008;(1):1-16. Jones HE, Martin PR, Heil SH, et.al. Treatment of opioid dependent pregnant women: clinical research issues. Journal of Substance Abuse Treatment. 2008;35(3): Stitely, Michael L.; Calhoun, Byron; Maxwell, Stefan; Nerhood, Robert; Chaffin, David. Prevalence of drug use in pregnant West Virginia patients. West Virginia Medical Journal. July Pritham, U. Breastfeeding Promotion for management neonatal abstinence syndrome. Journal of obstetric, gynecologic, and neonatal nursing. 2013;42, Jansson LM. AMB Clinical Protocol #21: Guidelines for breastfeeding and the drug dependent woman. Breastfeeding medicine. 2009; 4: Brown et al. Trends in Marijuana Use Among Pregnant and Nonpregnant reproductiveaged women. JAMA. 2017; 317(2): Room, R. Stigma, social inequality, alcohol problems and drug use. Drug and Alcohol Rev :

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem

2/28/2017. Substance Use Disorders + Pregnancy. Substance Use Disorders + Pregnancy. + Prevalence of the Problem Substance Use Disorders Pregnancy Laura Lander, MSW, LICSW, Assistant Professor Department of Behavioral Medicine and Psychiatry, WVU Celebrating Connections Conference - April 2017 Substance Use Disorders

More information

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society Pregnant Women Who Use Drugs: Stigma, Science and Society Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia

More information

The Opioid-Exposed Woman

The Opioid-Exposed Woman The Opioid-Exposed Woman Management Considerations for Labor and Delivery Jane Sublette, MS, RN, CNM, WHNP-BC Fairview Ridges Hospital Objectives Describe opioid-associated risks to the mother and fetus

More information

The Social Worker s Role in Medication Assisted Treatment

The Social Worker s Role in Medication Assisted Treatment The Social Worker s Role in Medication Assisted Treatment Rocky Ephraim Lucas, LICSW Behavioral Health Consultant, Kanawha City Health Center (Cabin Creek Health Systems) What is Medication-Assisted Treatment

More information

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin

More information

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION AND PREGNANCY L y n é e B r o w n, M A, C D P & D o n n a L i v i n g s t o n, R N A D A P T E D F R O M J i m W a l s h, M D Objectives: Recognize common fears and myths associated with substance

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons Marianna Corona Jennifer Foley September 12, 2017 Learning Objectives 2017 Improving Family Outcomes

More information

Module 6: Substance Use

Module 6: Substance Use Module 6: Substance Use Part 1: Overview of Substance Abuse I am Martha Romney and I am presenting on substance abuse. This module focuses on the healthy people 2020 objective to reduce substance abuse

More information

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of

More information

Child Welfare and Substance Abuse. Erica Tarasovitch, MSW Central Florida Behavioral Health Network

Child Welfare and Substance Abuse. Erica Tarasovitch, MSW Central Florida Behavioral Health Network Child Welfare and Substance Abuse Erica Tarasovitch, MSW Central Florida Behavioral Health Network Parental Substance Use Marijuana was the most commonly used illicit drug in 2006, accounting for 72.8

More information

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Holly Hills, Ph.D. June 13, 2017 Department of Mental Health Law and Policy Overview: Persons who have not been in

More information

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard

Opioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard Opioid Use in Pregnant Women and Prenatal Care Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard Objectives Summarize contextual and co-morbid factors observed among

More information

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Smoking Cessation in Pregnancy Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Tobacco Cessation in Pregnancy: Objective 1. Overview of the negative effects of tobacco abuse in

More information

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Beyond Birth: A Comprehensive Recovery Center serving parenting women Beyond Birth: A Comprehensive Recovery Center serving parenting women Session Objectives Highlight Plan of Safe Care Introduce the Beyond Birth Comprehensive Recovery Center Describe Levels of Care The

More information

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH

KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH IF THESE MOMS REALLY CARED ABOUT THEIR BABIES, THEY WOULD JUST QUIT Those who can quit, often do Addiction

More information

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids MAT IN PREGNANCY R. COREY WALLER MD, MS PRINCIPAL, HEALTH MANAGEMENT ASSOCIATES FACULTY, INSTITUTE FOR HEALTHCARE INNOVATION (IHI) CHAIR, LEGISLATIVE ADVOCACY COMMITTEE, ASAM KAYLA LIFE STAGE 1: ADOLESCENCE

More information

Maternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy

Maternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy Maternal Mental Health: Risk Factors, Ramifications, and Roles Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy Disclosures None Objectives for Today Review major maternal

More information

Brief History of Methadone Maintenance Treatment

Brief History of Methadone Maintenance Treatment METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what

More information

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018 Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018 Fear Shame Commitment Barriers Opportunities Fear Thalidomide induced phocomelia 1957 Fear Fetal Alcohol

More information

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.

Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC. Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC Key Issues Significant increase in number of pregnant women addicted to prescription

More information

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC Emergent Issues Affecting Early Intervention/ Early Childhood Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC Conversation Points Changing Demographics Emergent Trends

More information

SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS

SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS 1 SUBSTANCE-EXPOSED INFANTS Refers to infants exposed to alcohol and or other substances ingested

More information

1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT

1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES Susan Kilman LCSW, AADC THE PROBLEM ABOUT 1 IN 8 (8.7 MILLION) AGED 17 OR YOUNGER LIVE IN HOUSEHOLDS WITH AT LEAST ONE PARENT WHO HAD

More information

Many drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age.

Many drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age. 1 Chapter 12 Section 1 Objectives List six ways illegal drug use can be dangerous. State five reasons a person might try illegal drugs. Identify the reason drug abuse is especially dangerous to teens.

More information

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome Meghan Howell, MD FAAP Assistant Professor of Pediatrics Clinical Director, Tulane NICU Graduate Clinic Tulane University School

More information

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples

More information

Let s Clean Up the Dirty Talk:

Let s Clean Up the Dirty Talk: Let s Clean Up the Dirty Talk: How Stigma Impacts Prevention and Treatment of Substance Use Disorders Jennifer Michaels, MD, FASAM Medical Director, Brien Center Attending Psychiatrist, Berkshire Medical

More information

The Impact of the Opioid Crisis on Children

The Impact of the Opioid Crisis on Children The Impact of the Opioid Crisis on Children Guided Notes for Online Learning Name: Date: 1 Table of Contents Section 1: The Opioid Crisis Page 3 Section 2: Addiction Page 4 Section 3: Trauma Informed Care

More information

Pregnancy Smoking Intervention in NE Tennessee: Effectiveness Data from the First Two Years of TIPS

Pregnancy Smoking Intervention in NE Tennessee: Effectiveness Data from the First Two Years of TIPS Pregnancy Smoking Intervention in NE Tennessee: Effectiveness Data from the First Two Years of TIPS Beth A. Bailey, PhD Associate Professor of Family Medicine Director, Tennessee Intervention for Pregnant

More information

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit

More information

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016

Objectives. Care of the Neonate with Prenatal Opioid Exposure. What is Neonatal Abstinence Syndrome (NAS)? Increasing Incidence of NAS 8/27/2016 Care of the Neonate with Prenatal Opioid Exposure Heather Pratt Chavez, MD Ann Winegardner, MD Objectives Review the latest population data on neonates with prenatal opioid exposure Describe the acute

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment

9/19/13. Postpartum Counseling for Women in MAT. Katie Clark MSPH, CSAC. A little about Katie. Definitions. MAT: Medication-Assisted Treatment Postpartum Counseling for Women in MAT Katie Clark MSPH, CSAC A little about Katie SUD and PH crossroads BA Health Arts and Sciences Goddard College MSPH MCH UNC Project Lazarus, Yale, CHER Solutions LLC

More information

Safe Babies Foster Parent Training Program

Safe Babies Foster Parent Training Program Safe Babies Foster Parent Training Program Module 1: Introduction to the Safe Babies Program 1 Begin the process of group participation Learning outcomes Understand the purpose and origins of the Safe

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

Stigma, Myths, Realities Limit Access to Care

Stigma, Myths, Realities Limit Access to Care Stigma, Myths, Realities Limit Access to Care MARGARET RUKSTALIS, MD Director ACGME Addiction Medicine Fellowship @ Wake Forest School of Medicine No personal or family conflicts of interest or history

More information

Pregnancy, Opioid Addiction, and Care Issues in Virginia

Pregnancy, Opioid Addiction, and Care Issues in Virginia Pregnancy, Opioid Addiction, and Care Issues in Virginia Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics and Gynecology and Psychiatry Associate Director Addiction Medicine Virginia

More information

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome Opioid Use Disorder in Pregnancy Neonatal Abstinence Syndrome Opioid Use Disorder and Pregnancy Cont. 4.6 million women (or 3.8 percent) ages 18 and older misused prescription drugs in 2013. One-third

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

Child Welfare and MOMS: Building Partnerships to Improve Care

Child Welfare and MOMS: Building Partnerships to Improve Care Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly

More information

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women Michelle Tuten, Ph.D. Assistant Professor Department of Psychiatry and Behavioral Sciences and Johns

More information

PERINATAL TOBACCO USE

PERINATAL TOBACCO USE PERINATAL TOBACCO USE Child Fatality Task Force Meeting December 7, 2015 Erin McClain, MA, MPH You Quit, Two Quit, UNC Center for Maternal & Infant Health Percentage Women & Tobacco Use in NC 2 50 45 40

More information

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower. The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call

More information

INTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia

INTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia The American Journal on Addictions, 27: 92 96, 2018 Copyright 2018 American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/ajad.12687 Brief Report: Treating Women

More information

Funding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists

Funding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists A training offered by Dr. Beth Bailey, Associate Professor of Family Medicine, East Tennessee State University; and by the Tennessee Intervention for Pregnant Smokers (TIPS) Program Funding for TIPS provided

More information

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome Neonatal Nursing Education Brief: The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome https://www.seattlechildrens.org/healthcareprofessionals/education/continuing-medical-nursing-education/neonatalnursing-education-briefs/

More information

Harm Reduction Approaches:

Harm Reduction Approaches: Harm Reduction Approaches: Click Working to edit With Master Complexity title style Click to edit Master subtitle style Facilitated by: Dale Kuehl Clinical Day, May 1, 2014 Centre for Addiction and Mental

More information

Prenatal Substance Abuse: Improving Outcomes

Prenatal Substance Abuse: Improving Outcomes Prenatal Substance Abuse: Improving Outcomes Jennifer Yates, MSN Family Nurse Practitioner Children s Hospital of Wisconsin Child Advocacy and Protection Services Overview Discuss the Problems Health,

More information

Tobacco, Alcohol, and

Tobacco, Alcohol, and Healthier San Joaquin County Community Assessment 2011 Tobacco, Alcohol, and Drug Use Summary... 100 Indicators Tobacco Use... 101 Tobacco Use Among Pregnant Women... 103 Alcohol Consumption... 104 Adult

More information

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT OUTPATIENT TREATMENT WESTPORT, CONNECTICUT ABOUT CLEARPOINT At Clearpoint, we focus on healing the whole person: mind, body, and spirit. Our comprehensive care methods set clients up for long-term success

More information

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy

Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Centers for Disease Control and Prevention Central Appalachia: A Regional Response to an Opioid Epidemic in Pregnancy Jenna Meyer MPH, RNC-MNN, IBCLC Public Health Advisor Therapies for Opioid Dependent

More information

Talking with your doctor

Talking with your doctor SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may

More information

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome?

Care of the Neonate with Prenatal Opioid Exposure. Objectives. What is Neonatal Abstinence Syndrome (NAS)/ Neonatal Opiate Withdrawal Syndrome? Care of the Neonate with Prenatal Opioid Exposure Heather Pratt Chavez, MD Ann Winegardner, MD Objectives Review the latest population data on neonates with prenatal opioid exposure Describe the acute

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance

More information

The Opioid Scourge DR. CAROLINE CARNEY CHIEF MEDICAL OFFICER

The Opioid Scourge DR. CAROLINE CARNEY CHIEF MEDICAL OFFICER The Opioid Scourge NOUN: A PERSON OR THING THAT CAUSES GREAT TROUBLE OR SUFFERING SYNONYMS: AFFLICTION, BANE, CURSE, MENACE, BURDEN, EVIL DR. CAROLINE CARNEY CHIEF MEDICAL OFFICER 1,000,000,000,000 72,000

More information

EI Leadership April 24, 2018

EI Leadership April 24, 2018 Early Childhood Community Partnerships to Support Families Struggling with SUD EI Leadership April 24, 2018 Setting the Stage The issue of young children impacted by substance use disorders in families

More information

Community Health Needs Assessment Centra Southside Medical Center

Community Health Needs Assessment Centra Southside Medical Center Community Health Needs Assessment Centra Southside Medical Center 2017-2019 Healthy People 2020 Healthy People provides a framework for prevention for communities in the U.S. Healthy People 2020 is a comprehensive

More information

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine

Opioid Use Disorders and Pregnancy. Marcela Smid, MD Maternal-Fetal Medicine Opioid Use Disorders and Pregnancy Marcela Smid, MD Maternal-Fetal Medicine UNIVERSITY OF UTAH HEALTH, 2017 OBJECTIVES Definitions Epidemiology Pharmacology Effects on pregnancy Screening Treatment CARE

More information

HARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 UNIVERSITY OF UTAH HEALTH, 2018

HARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 UNIVERSITY OF UTAH HEALTH, 2018 HARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 OBJECTIVES Define Harm reduction. Understand how harm reduction theory is applied clinically. Explore how to analyze the spectrum of Harm Reduction

More information

PERINATAL TOBACCO USE

PERINATAL TOBACCO USE PERINATAL TOBACCO USE Child Fatality Task Force Perinatal Health Committee Meeting November 4, 2015 Erin McClain, MA, MPH You Quit, Two Quit, UNC Center for Maternal & Infant Health Percentage Women &

More information

Women in the Opioid Crisis: Pain, Pregnancy and Life Course

Women in the Opioid Crisis: Pain, Pregnancy and Life Course Women in the Opioid Crisis: Pain, Pregnancy and Life Course Mishka Terplan MD MPH FACOG FASAM Professor Departments Obstetrics & Gynecology and Psychiatry Virginia Commonwealth University Addiction Medicine

More information

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond Women and opioid use disorder: Optimizing care during pregnancy and beyond Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP Ashley L. Hodges, PhD, CRNP, WHNP-BC Disclosures Dr. Fogger has nothing to

More information

Managing drug misuse in pregnancy and beyond

Managing drug misuse in pregnancy and beyond Managing drug misuse in pregnancy and beyond Dr Emily Finch Clinical Director Addictions CAG, South London and Maudsley Foundation NHS Trust Rachel Evans, Adfam 1 / Aims of the session Update on management

More information

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works From the street to the NICU Richard Christensen, PA, CAS Johann Hari Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a

More information

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD 1 The National Academies of Sciences, Engineering and Medicine Regulatory Strategies of address prescription opioidrelated harms 4 th of November, 2016 Washington DC Product Labeling to Communicate Benefits

More information

5/30/ New England Summer School Lindy S. Keller, M.S., MLADC - NH Bureau of Drug & Alcohol Services. Objectives

5/30/ New England Summer School Lindy S. Keller, M.S., MLADC - NH Bureau of Drug & Alcohol Services. Objectives 2018 New England Summer School Lindy S. Keller, M.S., MLADC - NH Bureau of Drug & Alcohol Services Objectives Describe the neurological basis of addiction Explain how addiction manifests in various aspects

More information

Understanding Prenatal Drug Exposure

Understanding Prenatal Drug Exposure Understanding Prenatal Drug Exposure Prenatal Drug Exposure A mother s drug use hurts her unborn baby. Slide 2 Drug Categories Part 1 Prescription drugs: Prescribed by a doctor and used under a health

More information

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:

More information

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center

Opioid Use Disorder- Pregnancy Principles and Myths. Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center Opioid Use Disorder- Pregnancy Principles and Myths Brian Iriye MD and Farzad Kamyar MD High Risk Pregnancy Center History of NAS/NOWS Prior to 1875 infants not thought to be affected Congenital Morphinism

More information

Medication-Assisted Treatment (MAT) Overview

Medication-Assisted Treatment (MAT) Overview Medication-Assisted Treatment (MAT) Overview 2014 Opiate Conference: Don t Get Me Started Hyatt Regency, Columbus, Ohio June 30-July 1, 2014 Christina M. Delos Reyes, MD Medical Consultant, Center for

More information

Methadone and Pregnancy

Methadone and Pregnancy Methadone and Pregnancy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Charissa Patricelli, MD, CCFP, ABAM Clinical Associate Professor, Dept. of Family Practice UBC American Board of Addiction Medicine

More information

Outcomes of Infants with Neonatal Abstinence Syndrome

Outcomes of Infants with Neonatal Abstinence Syndrome Outcomes of Infants with Neonatal Abstinence Syndrome Caroline O. Chua, MD, FAAP Medical Director, Division of Neonatology Director, Neonatal Follow Up Clinic Nemours Children s Hospital Orlando, Florida

More information

This event is jointly sponsored by the HealthInsight New Mexico and NMPHA & NM CARES Health Disparities Center.

This event is jointly sponsored by the HealthInsight New Mexico and NMPHA & NM CARES Health Disparities Center. Jeanne Block, RN, MS Coordinator, Community Addictions Recovery Specialist (CARS) Program Integrated Addictions & Psychiatry Program Project ECHO, UNM Health Sciences Center Harm Reduction Coordinator

More information

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome

Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome Texas Strategies to Address the Opioid Crisis and Neonatal Abstinence Syndrome 1 Learning Objectives Become familiar with how the opioid epidemic is impacting Texas women Become familiar with Neonatal

More information

Progress Tracker. Photo - https://www.healthypeople.gov/

Progress Tracker. Photo - https://www.healthypeople.gov/ Progress Tracker Healthy People provides a framework for prevention for communities in the U.S. Healthy People 2020 is a comprehensive set of key disease prevention and health promotion objectives. The

More information

HIP Year 2020 Health Objectives related to Perinatal Health:

HIP Year 2020 Health Objectives related to Perinatal Health: PERINATAL HEALTH Perinatal health is the health and wellbeing of mothers and babies before, during, and after child birth. As described by Healthy People 2020, Pregnancy can provide an opportunity to identify

More information

9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN

9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN 1 ADDICTION PREVENTION & TREATMENT SAVES LIVES According to the Food and Drug Administration s standards for

More information

Why do people use drugs? Why do so many people use drugs? What should we do?

Why do people use drugs? Why do so many people use drugs? What should we do? Why do people use drugs? Why do so many people use drugs? What should we do? David Labby MD PhD Health Share of Oregon -- May 17, 2018 Learning Objectives 1. To increase understanding of societal determinants

More information

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place

More information

Open Recovery Ending the Stigma Fueling Addiction

Open Recovery Ending the Stigma Fueling Addiction Open Recovery Ending the Stigma Fueling Addiction Cigna s Substance Use Series Recovery Seminar May 16, 2018 Presented by Fay Zenoff, MBA 1 Presentation Overview Introduction Brief History & Marty Mann

More information

Prescription Opioids

Prescription Opioids What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made

More information

Noel Schenk MD. Davis Behavioral Health

Noel Schenk MD. Davis Behavioral Health Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by

More information

Opioid Overview Admiral Brett P. Giroir, M.D.

Opioid Overview Admiral Brett P. Giroir, M.D. A S S I S TA N T S E C R E TA RY F O R H E A LT H Opioid Overview Admiral Brett P. Giroir, M.D. Assistant Secretary for Health Senior Advisor for Opioid Policy @HHS_ASH August 20, 2018 SUBSTANCE ABUSE

More information

Understanding and Combating the Heroin Epidemic

Understanding and Combating the Heroin Epidemic Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the

More information

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING

More information

PREGNANCY SMOKING AND CHILD OUTCOMES FROM BIRTH TO 15 MONTHS: FINDINGS FROM NORTHEAST TENNESSEE. Beth Bailey, PhD

PREGNANCY SMOKING AND CHILD OUTCOMES FROM BIRTH TO 15 MONTHS: FINDINGS FROM NORTHEAST TENNESSEE. Beth Bailey, PhD PREGNANCY SMOKING AND CHILD OUTCOMES FROM BIRTH TO 15 MONTHS: FINDINGS FROM NORTHEAST TENNESSEE Beth Bailey, PhD Associate Professor of Family Medicine, East Tennessee State University Associate Director

More information

Patterns of Alcohol Use

Patterns of Alcohol Use Alcohol and Tobacco Learning Objectives 1) Describe the patterns of alcohol use, and the health risks and social problems that can result from alcohol use, abuse, and dependence 2) Explain treatment approaches

More information

Opioid use in pregnancy and Neonatal Abstinence Syndrome

Opioid use in pregnancy and Neonatal Abstinence Syndrome Opioid use in pregnancy and Neonatal Abstinence Syndrome Morissa Ladinsky, MD Assoc. Professor of Pediatrics Division of General Pediatrics and Adolescent Medicine UAB Objectives 1. Understand the magnitude,

More information

Medication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers

Medication-Assisted Treatment & Pregnancy. Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers Medication-Assisted Treatment & Pregnancy Dave Kneessy, MS, MAC, CAP, LMHC Regional Director Central Florida Treatment Centers Addiction/ Substance Use Disorder Addiction is a Biopsychosocial Disease Has

More information

Vivitrol Drug Court and Medication Assisted Treatment

Vivitrol Drug Court and Medication Assisted Treatment Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment

More information

Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids

Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids Public Policy Statement on Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids Background The American Society of Addiction Medicine (ASAM) is deeply committed

More information

Medication for the Treatment of Addiction (MAT)

Medication for the Treatment of Addiction (MAT) Medication for the Treatment of Addiction (MAT) Karol Kaltenbach, PhD Emeritus Professor of Pediatrics Sidney Kimmel Medical College at Thomas Jefferson University Terminology: Words Matter Medication

More information

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse

Science = Solutions For Substance Use Disorders and Infant Outcomes. Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions For Substance Use Disorders and Infant Outcomes Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Science = Solutions Increased Opioid Mortality: Greater

More information

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder Brett Giroir, U.S. Department of Health and Human Services Join the conversation at #OUDTreatment #EndTheStigma Expanding

More information

Medication Supported Recovery- A Review of Evidence-Based Practice

Medication Supported Recovery- A Review of Evidence-Based Practice Medication Supported Recovery- A Review of Evidence-Based Practice Andrew B. Mendenhall, MD, DABAM, DABFM, Senior Medical Director, Substance Use Disorder Services, Central City Concern 1 Objectives 1.

More information

Table of Contents VOLUME 1

Table of Contents VOLUME 1 VOLUME 1 A Accidents and Injuries from Alcohol... 1 Accidents and Injuries from Drugs..... 4 Addiction: Concepts and Definitions... 7 Addictive Personality............... 12 Adolescents, Drug and Alcohol

More information

Shatter the Stigma J e s s i c a C a n d e l a r i a L i p s e y, M S W R e g i s t e r e d C l i n i c a l S o c i a l W o r k I n t e r n

Shatter the Stigma J e s s i c a C a n d e l a r i a L i p s e y, M S W R e g i s t e r e d C l i n i c a l S o c i a l W o r k I n t e r n Shatter the Stigma J e s s i c a C a n d e l a r i a L i p s e y, M S W R e g i s t e r e d C l i n i c a l S o c i a l W o r k I n t e r n My Story Addiction, impacting more than 45 million Americans

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN. Lyn Raible, M.D., Ph.D. CMO, Aegis

REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN. Lyn Raible, M.D., Ph.D. CMO, Aegis REDUCING THE STIGMA OF OPIOID ADDICTION AMONG PERINATAL WOMEN Lyn Raible, M.D., Ph.D. CMO, Aegis ORGANIZATION The Opioid Crisis Breaking the Stigma Neurobiology of Opioid Addiction Treatment of Opioid

More information